Enhanced Lung Cancer Therapy via Co-Encapsulation of Docetaxel and Betulinic Acid
Docetaxel (DTX) and betulinic acid (BA) co-encapsulated poly-lactic co-glycolic acid (PLGA) nanoparticles (NPs) were developed for enhanced lung cancer activity in vitro. Poly (lactic-co-glycolic acid) (PLGA) was used as an encapsulating polymer along with polyvinyl alcohol (PVA) as a stabilizing ba...
Saved in:
Main Authors: | Trideep Saikia (Author), Prakash Rajak (Author), Bhanu P. Sahu (Author), Lima Patowary (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target -Anti-cancer Potential of Nano-betulinic Acid in Lung Cancer-
by: Jayeeta Das, et al.
Published: (2016) -
Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy
by: Weiping Cui, et al.
Published: (2019) -
Development of Paclitaxel Proliposomal Dry Powder Inhaler (PTX-PLM-DPI) by Freeze-Drying Method for Lung Cancer
by: Chinmoyee Borah, et al.
Published: (2024) -
Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique
by: Li S, et al.
Published: (2020) -
Betulinic Acid Enhances the Viability of Random-Pattern Skin Flaps by Activating Autophagy
by: Jiafeng Li, et al.
Published: (2019)